Clinical Trials on Recurrent GBM in France

Total 576 results

Assistance Publique - Hôpitaux de Paris

Recruiting

Certolizumab in Recurrent Implantation Failure (RIF) (CERTIFY)

Recurrent Unexplained Implantation Failure

France
Centre Hospitalier Universitaire, Amiens

Completed

Electrophysiologic Study of Perioperative Monitoring of the Recurrent Laryngeal Nerve: Impaired Vocal Cord Movement After Thyroidectomy (NERLICORDE)

Recurrent Laryngeal Nerve

France
University Hospital, Angers

Unknown

Use of Metabolomics for the Identification of Endometrial Biomarkers for IRPL and RIF After in Vitro Fertilization (ENDOMETAB)

Recurrent Implantation Failure | Recurrent Pregnancy Loss

France
CarThera

Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM (SONOBIRD)

Glioblastoma | GBM | Recurrent Glioblastoma

France, United States, Spain, Belgium, Germany, Italy, Netherlands
Assistance Publique Hopitaux De Marseille

Unknown

Evaluation of the Impact of the Level of Mindfulness on the Management of Patients With Recurrent Depressive Disorders by the Mindfulness Based Cognitive Therapy ( MBCT ): an Exploratory Study (MBCT)

Patients With Recurrent Depressive Disorders

France
University Hospital, Toulouse

Completed

Sperm DNA Fragmentation in Recurrent Pregnancy Loss (PARTHOM)

RECURRENT PREGNANCY LOSS

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France; Merck Serono International SA; Ligue contre...

Completed

Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer (ELAN-UNFIT)

Head Neck Cancer Squamous Cell Recurrent

France
University Hospital, Strasbourg, France

Not yet recruiting

Evaluation of the Efficacy and Safety of Local Cryotherapy Treatment of Recurrent Head and Neck Cancer in Irradiated Areas: a Pilot Study (CRYORL)

Recurrent Head and Neck Cancer | Local Cryotherapy Treatment

France
Hospices Civils de Lyon

Completed

Post-transition Clinical and Socio-professional Future in Adult Patients With Recurrent Multifocal Chronic Osteitis (ESPERANTO)

Chronic Recurrent Multifocal Osteomyelitis

France
UNICANCER
Bristol-Myers Squibb

Completed

Nivolumab in Recurrent and/or Metastatic SCCHN (TopNIVO)

Recurrent and/or Metastatic Platinum-refractory SCCHN

France
Centre Hospitalier Universitaire, Amiens

Recruiting

Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage (ERIM)

Recurrent Miscarriage | Immune System | Repeated Embryo Implantation Failure

France
Assistance Publique - Hôpitaux de Paris

Completed

Treatment With AZD4547 for Recurrent Malignant Glioma Expressing FGFR-TACC Gene Fusion" (TARGET)

Recurrent IDHwt Gliomas With FGFR3-TACC3 Fusion | Recurrent IDHwt Gliomas With FGFR1-TACC1 Fusion

France
Centre Hospitalier Universitaire de Nice

Active, not recruiting

Evaluation of a Phyto Aromatherapy Treatment in the Management of Recurrent Cystitis (CYSTALTERNA)

Cystitis Recurrent

France
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation (AGIR)

Recurrent IDH1/2 Mutated Glioma

France
UNICANCER

Completed

A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes (ORL03)

Recurrent Head and Neck Cancer | Metastatic Head and Neck Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC (ELANFIT)

Metastatic or Recurrent Head and Neck Squamous Cell Cancer

France
Centre Leon Berard
National Cancer Institute, France; Fondation ARC

Completed

Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive (PIK-ORL)

Head and Neck Neoplasms | Neoplasm Metastasis | Progressive Disease | Recurrent Disease

France
Hospices Civils de Lyon

Completed

Olaparib in Recurrent IDH-mutant Glioma (OLAGLI)

Recurrent IDH | Mutant High Grade Glioma

France
University of California, Irvine

Completed

Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections

Recurrent Urinary Tract Infection

United States
Centre Leon Berard
GlaxoSmithKline

Recruiting

PREventing Second Cancers With DOSTARlimab (PREDOSTAR)

Recurrent Cancer | Second Cancer | Primary Cancer

France
Centre Georges Francois Leclerc

Completed

Brachytherapy for Recurrent Prostate Cancer (CAPRICUR)

Recurrent Prostate Cancer | Brachytherapy Remedial

France
Assistance Publique Hopitaux De Marseille

Completed

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas (CEVOREM)

Recurrent Meningiomas | Resistant Meningiomas

France
Cliniques universitaires Saint-Luc- Université...

Terminated

Efficacy of SU 011248 in Head And Neck Carcinoma

Recurrent Disease | Squamous Cell Head and Neck Carcinoma | Palliative Treatment

France, Belgium
University Hospital Virgen de las Nieves
Hospital Universitario Reina Sofia de Cordoba; Hospitales Universitarios Virgen... and other collaborators

Recruiting

SCAP vs HIFU for Recurrent Prostate Cancer After Radiation Therapy (SALVPROST)

Recurrent Prostate Cancer | Cryotherapy | High Intensity Focused Ultrasounds

Spain, France
Poitiers University Hospital

Recruiting

Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy

Recurrent Paralysis of Vocal Cords

France
Medical University of Vienna

Recruiting

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT (MEMMAT)

Medulloblastoma Recurrent | Ependymoma Recurrent | ATRT Recurrent

Austria, Sweden, France, Spain, United States, Czechia, Denmark, Norway
Children's Oncology Group

Completed

VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors

Refractory or Recurrent Solid Tumors, Excluding CNS Tumors

United States, Canada
Imagine Institute

Recruiting

Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort " REPA ") (REPA)

Juvenile Recurrent Respiratory Papillomatosis

France
Lionel Bouvet

Completed

Chewing Gum and Gastric Emptying of Water

Comparison of Gastric Emptying Rate of Water When Chewing Gum or Not

France
Groupe Oncologie Radiotherapie Tete et Cou
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (TPEx)

Squamous Cell Head and Neck Carcinoma | Recurrent or Metastatic Disease

France, Belgium
Eli Lilly and Company
Children's Oncology Group

Completed

A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

Recurrent Tumor | Pediatric Solid Tumor | Refractory Tumor | CNS Malignancies

United States
Assistance Publique - Hôpitaux de Paris

Completed

Integrative Approach to Identify Environmental Risk Factors for CC-17 Group B Streptococcal Neonatal Infection (STREPB17)

Vaginal Colonization With GBS

France
Curium PET France

Active, not recruiting

A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer (Python)

Prostate Cancer Recurrent

France
Hospices Civils de Lyon

Completed

Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI (HISTO-RAD)

Prostate Cancer Recurrent

France
OM Pharma SA
Parexel

Recruiting

A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing

Recurrent Wheezing | Wheezing Lower Respiratory Illness

United States
University Hospital, Brest

Active, not recruiting

Hydroxychloroquine for Prevention of Recurrent Miscarriage. (BBQ)

Recurrent Miscarriage | First Trimester Abortion

France
Grupo Español de Investigación en Cáncer de Ovario
GlaxoSmithKline; Hoffmann-La Roche; Apices Soluciones S.L.; AGO Study Group; ARCAGY... and other collaborators

Active, not recruiting

Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)

Recurrent Ovarian Carcinoma

France, Spain, Belgium, Italy, Germany
University of California, Irvine

Recruiting

Adherence to Vaginal Estrogen Therapy in Hypoestrogenic Women With Recurrent Urinary Tract Infections

Recurrent Urinary Tract Infection | Hypoestrogenism

United States
Hospices Civils de Lyon
Exeliom Biosciences

Recruiting

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients (LIVEDIFF)

Clostridioides Difficile Infection | Recurrent Infection

France
ABX advanced biochemical compounds GmbH

Completed

F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence

Prostate Cancer | Prostate Cancer Recurrent

France
GOG Foundation
National Cancer Institute (NCI)

Completed

Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma

United States
Novartis Pharmaceuticals

Completed

Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme

Recurrent Glioblastoma Multiforme

United States, Belgium, Australia, Spain, France, Canada
Institut National de la Santé Et de la Recherche...

Completed

Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis (RAPAMI)

Inclusion Body Myositis (IBM)

France
National Cancer Institute (NCI)

Active, not recruiting

Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Recurrent Ewing Sarcoma | Recurrent Osteosarcoma | Stage III Osteosarcoma AJCC v7 | Stage IV Osteosarcoma AJCC v7 | Stage IVA Osteosarcoma AJCC v7 | Stage IVB Osteosarcoma AJCC v7 | Metastatic Osteosarcoma | Metastatic Ewing Sarcoma | Unresectable Ewing Sarcoma | Unresectable Osteosarcoma

France
UNICANCER

Completed

Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck (NISCAHN)

Metastatic Cancer | Salivary Gland Carcinoma | Recurrent Cancer

France
Children's Oncology Group
National Cancer Institute (NCI)

Active, not recruiting

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Osteosarcoma | Refractory Osteosarcoma

United States
NovoCure Ltd.

Completed

Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)

Recurrent Glioblastoma Multiforme

United States, Israel, Switzerland, Austria, Czech Republic, France, Germany
Amgen

Completed

Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients

Locally Recurrent and Metastatic Breast Cancer

United States, United Kingdom, Denmark, Poland, Belgium, Hungary, Spain, Austria, France, Australia, Netherlands, Finland, India
Geron Corporation

Completed

Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer

Locally Recurrent or Metastatic Breast Cancer

United States, Canada
Fondation Ophtalmologique Adolphe de Rothschild

Completed

Metalloproteinases and Recurrent Corneal Erosion Syndrome (MERCURE)

Recurrent Corneal Erosion Syndrome

France

Clinical Trials on Recurrent GBM in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations